Rhabdomyolysis: a review, with emphasis on the pediatric population

Essam F Elsayed1, Robert F Reilly

  • 1Department of Internal Medicine, Section of Nephrology, VA North Texas Health Care System, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA. Essam.Elsayed@va.gov

Insights

Rhabdomyolysis, a condition causing muscle breakdown, is a frequent cause of acute kidney injury (AKI). Early recognition and hydration are key to preventing kidney damage, especially in children.

Area of Science:

  • Nephrology
  • Neurology
  • Genetics

Background:

  • Rhabdomyolysis is a significant clinical syndrome, contributing to 7% of acute kidney injury (AKI) cases in the USA.
  • Common causes include trauma, exercise, medications, and infections, with infections and inherited disorders being prevalent in pediatric cases.
  • Key symptoms include myalgias, weakness, and dark urine, often accompanied by elevated creatinine kinase and myoglobin levels.

Purpose of the Study:

  • To summarize the causes, diagnosis, and management of rhabdomyolysis.
  • To highlight the importance of early recognition in preventing acute kidney injury.
  • To discuss the role of genetic testing in suspected inherited forms of rhabdomyolysis.

Main Methods:

  • Clinical review of rhabdomyolysis cases.
  • Analysis of diagnostic markers including creatinine kinase and myoglobin.
  • Consideration of muscle biopsy and genetic testing for specific patient groups.

Main Results:

  • Rhabdomyolysis is a common cause of AKI, particularly in children due to infections or inherited disorders.
  • Diagnosis relies on clinical suspicion supported by elevated creatine kinase and myoglobin levels.
  • Aggressive hydration is crucial for preventing AKI.

Conclusions:

  • Early identification and prompt treatment, primarily aggressive hydration, are vital for preventing acute kidney injury in rhabdomyolysis.
  • Genetic testing and muscle biopsy are important for diagnosing recurrent or suspected metabolic myopathies.
  • Further research into pathophysiology and genetics may lead to novel therapies for rhabdomyolysis.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...